Armon Sharei
Company: SQZ Biotechnologies
Job title: CEO & Founder
Seminars:
Live Panel Q&A – Ask the Speakers Your Burning Questions 10:40 am
day: Day Two
2nd Generation Antigen Presenting Cells for Multiple KRAS Mutations 9:25 am
SQZ APC mechanism overcomes challenges of previous cancer vaccines with CD8 T-cell activation and can be enhanced with mRNA cargo combinations SQZ APC clinical program overview: Safety and manufacturability of SQZ’s APC candidate in solid tumors Preclinical data for SQZ’s enhanced APC platform in targeting KRAS G12D and G12V mutationRead more
day: Day Two